Orzáez, M <br/><br/>
Intrinsic caspase-8 activation mediates sensitization of erlotinib-resistant tumor cells to erlotinib/cell-cycle inhibitors combination treatment.  [electronic resource] 

 -  Cell death & disease  Oct 2012 
 - e415 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2041-4889 
<br/><br/><label>Standard No.: </label>10.1038/cddis.2012.155  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Apoptosis--drug effects<br/>Caspase 8--genetics<br/>Cell Cycle--drug effects<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Cyclin A--antagonists & inhibitors<br/>Cyclin-Dependent Kinase 2--antagonists & inhibitors<br/>Drug Resistance, Neoplasm--drug effects<br/>Drug Therapy, Combination<br/>Erlotinib Hydrochloride<br/>Humans<br/>Neoplasms--drug therapy<br/>Quinazolines--pharmacology